Evaluation of anti-cancer and anti-enzyme activities of imidazole derivative molecules with theoretical calculations   
Yazarlar (7)
Dr. Öğr. Üyesi Aslıhan Hatun ÇAÇAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Halis Karataş
Erciyes Üniversitesi, Türkiye
Burak Tüzün
Cumhuriyet Üniversitesi, Türkiye
Parham Taslımı
Bartın Üniversitesi, Türkiye
Prof. Dr. Ercan ÇAÇAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Zülbiye Kökbudak
Erciyes Üniversitesi, Türkiye
Sevim Gürdaş Mazlum
Cumhuriyet Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Journal of Molecular Structure
Dergi ISSN 0022-2860 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q2
Makale Dili İngilizce
Basım Tarihi 12-2025
Cilt No 1347
Sayı 1
DOI Numarası 10.1016/j.molstruc.2025.143264
Makale Linki https://doi.org/10.1016/j.molstruc.2025.143264
Özet
Nitrogen-containing heterocycles, known for their biological activity, were synthesized as four novel imidazole-based compounds via the reaction of guanyl hydrazones with 2-bromoacetyl naphthalene. The aim of this study was to synthesize and characterize these compounds and evaluate their potential as cholinesterase inhibitors and anticancer agents. Structural elucidation was performed using ¹H NMR, ¹³C NMR, FTIR, and MS. All compounds exhibited strong AChE and BChE inhibitory activities, with Ki values ranging from 131.44 to 415.54 nM (AChE) and 95.74 to 154.62 nM (BChE). IC₅₀ values confirmed potent inhibition. MTT assays demonstrated dose-dependent antiproliferative effects, with greater cytotoxicity observed in A2780 ovarian cancer cells than in MIA PaCa-2 pancreatic cells. In silico studies, including Gaussian (B3LYP, HF, M062X/6-31++G(d,p)), molecular docking, and ADME/T analyses, supported the pharmacological potential of these compounds. These findings highlight their promise as candidates for further development in cholinesterase inhibition and cancer therapy.
Anahtar Kelimeler
Anti-proliferative activity | Enzyme inhibition | Guanyl hydrazone | In silico analyses